Boston Scientific reports revenue growth in Q2

07/29/2013 | Reuters

Boston Scientific said that its revenue grew 2% during the second quarter, excluding foreign exchange effects and the impact from divested businesses. The company said sales of its neuromodulation devices rose 21% during that period and added that while sales of its stents and defibrillators decreased, the rate of decline was slower in the second quarter compared with that of the first quarter.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL